Integrum AB (publ) (INTEG-B.ST)

SEK 18.65

(3.04%)

Operating Expenses Summary of Integrum AB (publ)

  • Integrum AB (publ)'s latest annual operating expenses in 2023 was 90.57 Million SEK , up 5.16% from previous year.
  • Integrum AB (publ)'s latest quarterly operating expenses in 2024 Q1 was 26.83 Million SEK , down 0.0% from previous quarter.
  • Integrum AB (publ) reported a annual operating expenses of 86.12 Million SEK in annual operating expenses 2022, up 59.49% from previous year.
  • Integrum AB (publ) reported a annual operating expenses of 54 Million SEK in annual operating expenses 2021, up 52.72% from previous year.
  • Integrum AB (publ) reported a quarterly operating expenses of 19.55 Million SEK for 2023 Q2, down -13.52% from previous quarter.
  • Integrum AB (publ) reported a quarterly operating expenses of -2.00 SEK for 2023 FY, up 5.16% from previous quarter.

Annual Operating Expenses Chart of Integrum AB (publ) (2023 - 2013)

Historical Annual Operating Expenses of Integrum AB (publ) (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 90.57 Million SEK 5.16%
2022 86.12 Million SEK 59.49%
2021 54 Million SEK 52.72%
2020 35.35 Million SEK -5.74%
2019 37.51 Million SEK -13.5%
2018 43.37 Million SEK 42.08%
2017 30.52 Million SEK 23.97%
2016 24.62 Million SEK 117.16%
2015 11.33 Million SEK -6.88%
2014 12.17 Million SEK -6.85%
2013 13.07 Million SEK 0.0%

Peer Operating Expenses Comparison of Integrum AB (publ)

Name Operating Expenses Operating Expenses Difference
Acarix AB (publ) 82.85 Million SEK -9.32%
ADDvise Group AB (publ) 611.8 Million SEK 85.196%
ADDvise Group AB (publ) 611.8 Million SEK 85.196%
Arcoma AB 53.25 Million SEK -70.081%
Bactiguard Holding AB (publ) 4.96 Million SEK -1722.731%
BICO Group AB (publ) 2.84 Billion SEK 96.82%
Boule Diagnostics AB (publ) 210.44 Million SEK 56.962%
CellaVision AB (publ) 295.99 Million SEK 69.4%
Clinical Laserthermia Systems AB (publ) 68.93 Million SEK -31.396%
Chordate Medical Holding AB (publ) 1.3 Million SEK -6818.17%
C-Rad AB (publ) 3.8 Million SEK -2283.461%
Duearity AB (publ) 21.58 Million SEK -319.604%
Dignitana AB (publ) 74.73 Million SEK -21.189%
Episurf Medical AB (publ) 2.7 Million SEK -3254.5%
Getinge AB (publ) 10.75 Billion SEK 99.158%
Scandinavian Real Heart AB (Publ) 18.22 Million SEK -396.866%
Iconovo AB (publ) 63.35 Million SEK -42.96%
Luxbright AB (publ) 23.09 Million SEK -292.245%
Mentice AB (publ) 237.06 Million SEK 61.794%
OssDsign AB (publ) 175.6 Million SEK 48.422%
Paxman AB (publ) 133.8 Million SEK 32.308%
Promimic AB (publ) 48.55 Million SEK -86.545%
Qlife Holding AB (publ) 162.38 Million SEK 44.224%
SciBase Holding AB (publ) 69.97 Million SEK -29.432%
ScandiDos AB (publ) 61.03 Million SEK -48.385%
Sectra AB (publ) 39.06 Million SEK -131.86%
Sedana Medical AB (publ) 174.52 Million SEK 48.105%
Senzime AB (publ) 141.51 Million SEK 36.0%
SpectraCure AB (publ) 12.12 Million SEK -646.797%
Stille AB 87.21 Million SEK -3.844%
Vitrolife AB (publ) 5.56 Billion SEK 98.373%
Xvivo Perfusion AB (publ) 440.92 Million SEK 79.459%